testosterone products (any) — CareFirst (Caremark)
Gender dysphoria / transgender and gender diverse persons
Initial criteria
- Diagnosis of gender dysphoria confirmed
- Testosterone is used as part of gender-affirming hormone therapy according to accepted compendial use
Reauthorization criteria
- Ongoing need for testosterone therapy is confirmed for gender affirmation
Approval duration
12 months